Zacks.com on MSN3d
VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales
Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $3.98 per share for the fourth quarter of 2024, ...
Vertex Reports Fourth Quarter and Full Year 2024 Financial Results
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...
The Chemical Engineer7d
FDA approves ‘first’ of new class of non-addictive drugs for severe pain
The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...
Wall Street Journal14d
Vertex Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Pharmaceutical Technology15d
FDA approves Vertex’s acute pain treatment Journavx
Vertex has set the therapy’s wholesale acquisition cost at ... we have the opportunity to change the paradigm of acute pain management and establish a new standard of care.” Journavx is generally well ...
Pharmaceutical Technology15d
All change in Germany – confidential pricing in, IRP out
Eventually, this argument persuaded Federal Minister of Health Karl Lauterbach, but pressure from the statutory health insurance (Gesetzliche Krankenversicherung, GKV) meant that the final form of the ...
WVTM 1316d
FDA approves new pain drug Journavx as opioid alternative
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...
The Daily News16d
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 ...
Yahoo Finance23d
Vertex Energy, Inc. Successfully Emerges From Chapter 11 With Renewed Sustainable Capital Structure
HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...
Business Standard24d
Microsoft's Satya Nadella tops HSBC Hurun Global Indians List 2024
The youngest entrepreneur on the list is 27-year-old Tanay Tandon, co-founder of Commure. The list features 12 women, leading with Reshma Kewalramani of Vertex Pharmaceuticals, followed by Jayshree ...
standard-journal24d
Vertex Energy, Inc. Successfully Emerges From Chapter 11 With Renewed Sustainable Capital Structure
Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates, today announced it has successfully completed ...